Main Workshop DAY 3 - Thursday April 16, 2026: 7am - 5:30pm
"AGENDA - Mass Spectrometry, Chromatography, and Sample Preparation - Must-Know Breakthroughs, Developments, and Best Practices"
| 07:00am-08:00am: | Start your day at WRIB with Networking Continental Breakfast in the Exhibit |
Session 1: How much is AI/ML really helping in Discovery/Regulated Bioanalysis, and IRA?
Chair: Mr. John Smeraglia, Vice President, Global Head of Integrated Bioanalysis, AstraZeneca| 08:00am-08:20am: |
Dr. Jean-Claude Marshall, Head of Clinical Assays, Supply & Logistics, Moderna "The Use of Artificial Intelligence for Regulated Bioanalytical Testing" |
| 08:20am-08:40am: |
Dr. Jim Shen, Executive Director Precision Medicine, Bioanalytical & Translational Sciences, Bristol Myers Squibb "Bioanalysis, transitioning toward an agentic tomorrow" |
| 08:40am-09:00am: |
Dr. Gary Jenkins, Senior Director Quantitative, Translational & ADME Sciences , AbbVie "How Much is AI/ML Really Helping in Drug Discovery and Bioanalysis?" |
| 09:00am-09:20am: |
Dr. Ola Saad, Senior Director BioAnalytical Sciences, Genentech "Enhancing Immunogenicity Risk Assessment and PD Monitoring through High-Throughput MAPPs Technology" |
| 09:20am-10:10am: | Networking Coffee Break with Morning Snacks in the Exhibit |
| 10:10am-10:30am: |
Dr. Jean-Claude Marshall, Head of Clinical Assays, Supply & Logistics, Moderna
Dr. Jim Shen, Executive Director Precision Medicine, Bioanalytical & Translational Sciences, Bristol Myers Squibb Dr. Gary Jenkins, Senior Director Quantitative, Translational & ADME Sciences , AbbVie Dr. Ola Saad, Senior Director BioAnalytical Sciences, Genentech "Panel Discussions on How much is AI/ML really helping in Discovery/Regulated Bioanalysis, and IRA?" |
Session 2: Novel Modalities: Next-generation ADC, Antibody-LNP & Antibody-siRNA Conjugates, Is MS up to the Challenge?
Chair: Dr. Aaron Teitelbaum , Director LC-MS & Scientific Monitoring, Boehringer Ingelheim| 10:30am-10:50am: |
Ms. Lina Luo, Director Regulated Bioanalysis , Bristol Myers Squibb "Innovative Bioanalytical Strategies and Assay Designs for Next Generation Antibody-Drug Conjugate Pharmacokinetics in Support of Regulated Studies" |
| 10:50am-11:10am: |
Ms. Hetal Sarvaiya, Director Biologics Characterization, Bioanalysis & Proteomics, AbbVie "Bioanalytical Challenges and Strategies for Novel Genetic Medicine Modalities" |
| 11:10am-11:30am: |
Dr. Long Yuan, Director, Head of Bioanalytical Group, Biogen "Current Challenges and Strategies for Bioanalysis of Antibody-Oligonucleotide Conjugates" |
| 11:30am-11:50am: |
Ms. Lina Luo, Director Regulated Bioanalysis , Bristol Myers Squibb
Ms. Hetal Sarvaiya, Director Biologics Characterization, Bioanalysis & Proteomics, AbbVie Dr. Long Yuan, Director, Head of Bioanalytical Group, Biogen "Panel Discussions on Novel Modalities: Next-generation ADC, Antibody-LNP & Antibody-siRNA Conjugates, Is MS up to the Challenge?" |
Session 3: Unique & Advanced Applications of MS: T Cell Engagers, MsAbs, Total/Subclasses IgG, and Low-abundance Biomarkers
Chair: Dr. Xiaorong Liang, Senior Director, Head of Small Molecule Development Bioanalysis, Genentech| 11:50am-12:10pm: |
Dr. John Kellie, Group Director Integrated Bioanalysis, AstraZeneca "Mass Spectrometry in Discovery Bioanalysis for T-cell Engagers and Multispecific Antibodies" |
| 12:10pm-01:10pm: |
Sit-down Hot Buffet Networking Lunch downstairs at Marsalis B Note: Lunch Desserts and Coffee/Tea are served in the Exhibit Room |
| 01:10pm-01:30pm: |
Dr. Alexander Braun, Director R&D, Biomarker Discovery & Bioanalytical Lead, Takeda "Evolution of Immunoglobulin Quantitation Assays: A Cross-Comparison Case Study" |
| 01:30pm-01:50pm: |
Dr. Y-J Xue, Senior Director Precision Medicine, Bioanalytical & Translational Sciences, Bristol Myers Squibb "Uncovering Molecular Signatures: Glycoprotein Biomarkers for Alzheimer's Disease via Advanced Mass Spectrometry" |
| 01:50pm-02:10pm: |
Dr. John Kellie, Group Director Integrated Bioanalysis, AstraZeneca
Dr. Alexander Braun, Director R&D, Biomarker Discovery & Bioanalytical Lead, Takeda Dr. Y-J Xue, Senior Director Precision Medicine, Bioanalytical & Translational Sciences, Bristol Myers Squibb "Panel Discussions on Unique & Advanced Applications of MS: T Cell Engagers, MsAbs, Total/Subclasses IgG, and Low-abundance Biomarkers " |
Session 4: Are there still Industry/Regulators’ Concerns in using IA-MS (Hybrid Assay) for Regulated Bioanalysis?
Chair: Dr. Jian Wang, Senior Director of Bioanalysis & Biomarkers, Crinetics| 02:10pm-02:30pm: |
Dr. Anton Rosenbaum, Executive Director, Head of Bioanalytical Sciences, Vera "Comprehensive performance evaluation of a hybrid LBA-LC–MS/MS method for the quantification of atacicept, a recombinant Fc fusion protein, from human serum" |
| 02:30pm-02:50pm: |
Dr. Marcela Araya, Group Leader Pharmacokinetics, Dynamics & Metabolism, Pfizer "Where Hybrid LC-MS/MS Fits: Evolution, Challenges, and Regulatory Expectations" |
| 02:50pm-03:10pm: |
Dr. Tom Verhaeghe, Senior Director, Global Head of Development PK Bioanalysis, J&J "The application of Hybrid LC-MS/MS for the quantitative bioanalysis of proteins: 2 case studies." |
| 03:10pm-04:10pm: |
Networking Break with Afternoon Snacks, and Wine and Beer Reception in the Exhibit |
| 04:10pm-04:30pm: |
Dr. Anton Rosenbaum, Executive Director, Head of Bioanalytical Sciences, Vera
Dr. Marcela Araya, Group Leader Pharmacokinetics, Dynamics & Metabolism, Pfizer Dr. Tom Verhaeghe, Senior Director, Global Head of Development PK Bioanalysis, J&J "Panel Discussions on Are there still Industry/Regulators’ Concerns in using IA-MS (Hybrid Assay) for Regulated Bioanalysis?" |
Session 5: 2026 White Paper in Bioanalysis
| 04:30pm-05:30pm: |
Mr. John Smeraglia, Vice President, Global Head of Integrated Bioanalysis, AstraZeneca Dr. Aaron Teitelbaum , Director LC-MS & Scientific Monitoring, Boehringer Ingelheim Dr. Xiaorong Liang, Senior Director, Head of Small Molecule Development Bioanalysis, Genentech Dr. Jian Wang, Senior Director of Bioanalysis & Biomarkers, Crinetics "Recommendations on Mass Spectrometry, Chromatography and Sample Preparation and Panel Discussions for 2026 White Paper in Bioanalysis" |
